Bayer

Update in progress

BAYN.DE (XETRA)

Company RatingAt Risk
SectorHealthcare
IndustryDrug Manufacturers - General

Based in Leverkusen, Germany, Bayer is a global life sciences company with three segments: Pharmaceuticals, Consumer Health, and Crop Science. Pharmaceuticals develops prescription medicines (cardiology, women’s health), oncology, hematology, ophthalmology, imaging agents, and cell/gene therapies. Consumer Health provides OTC medicines, vitamins, dermatology, allergy, cough/cold, pain, and digestive care. Crop Science offers crop protection, seeds, plant traits, digital farming tools, and seed processing. Products reach wholesalers, pharmacies, supermarkets, online retailers, hospitals, and farmers.

Company score

Sentiment: -1.40; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: -1.78; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: -3.29; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: -2.58; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: -2.13; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: -1.77; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive